NCT05685147View on ClinicalTrials.gov

An Randomized Double Blind Controlled Trial of niPGT-A in Women With RPL

NANot yet recruitingINTERVENTIONAL

Enrollment

152

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

February 27, 2025

Study Completion Date

February 27, 2026

Conditions

Infertility

Interventions

GENETIC

Non-invasive Preimplantation genetic testing for aneuploidy status

In the intervention group, comprehensive chromosome screening using NGS will be performed according to the recommendations of the company in all SCM samples. Sequence of replacement shall be altered by the NiPGT result after morpholgy.

Trial Locations (1)

Unknown

The University of Hong Kong, Hong Kong

All Listed Sponsors

lead

Queen Mary Hospital, Hong Kong

OTHER

NCT05685147 - An Randomized Double Blind Controlled Trial of niPGT-A in Women With RPL | Biotech Hunter | Biotech Hunter